A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to BCG
Related studies linked through entity extraction aliases.
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Status
- RECRUITING
- Phase
- PHASE2
A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi
- Status
- NOT_YET_RECRUITING
- Phase
- NA
First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluating the Safety and Immunogenicity of MTBVAC
- Status
- RECRUITING
- Phase
- PHASE2
BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
- Status
- RECRUITING
- Phase
- NA
BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population
- Status
- WITHDRAWN
- Phase
- PHASE4
Non-specific Effects of BCG in Under-five Children
- Status
- UNKNOWN
- Phase
- N/A
Coadministration of GA2 Sporozoites With Adjuvants
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
- Status
- RECRUITING
- Phase
- PHASE3
Propranolol Adjuvant Treatment of Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
- Status
- COMPLETED
- Phase
- PHASE4
Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
EMaBS TB Vaccine Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2